InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Tag-Assisted Peptide Synthesis (TAPS) Services Market”-, By Technology (Chemical Synthesis with Tags, Hybrid Synthesis, C-Terminal Amidation Synthesis), By Application (Therapeutics, Drug Discovery, Research), By End-User (Pharmaceutical and Biotechnology Companies, CDMOs/CROs, Academic and Research Institutes), and Global Forecasts, 2025-2034 And Segment Revenue and Forecast To 2034.”
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market Size is predicted to grow at a 9.2 % CAGR during the forecast period for 2025-2034.
Read this Research Report Sample: https://www.insightaceanalytic.com/request-sample/3107
Tag-assisted peptide synthesis (TAPS) services refer to specialized contract services that utilize TAPS technology to synthesize complex or challenging peptides with greater efficiency and higher purity than conventional methods. TAPS is an advanced technique that employs a removable solubilizing tag to facilitate the stepwise elongation of peptides, making it particularly effective for hydrophobic or aggregation-prone sequences, long-chain peptides exceeding 30 amino acids, and peptides that are difficult to purify due to poor solubility.
The tag enhances solubility in both aqueous and organic solvents, simplifying purification processes such as HPLC and enabling the production of high-quality peptides for therapeutic, research, and industrial applications. The rising adoption of personalized treatments, such as neoantigen cancer vaccines and patient-specific peptide therapeutics, is driving demand for custom peptide synthesis with rapid turnaround times and high purity.
Peptides are also finding growing uses in beauty, functional foods, and diagnostics (such as biomarker assays), which opens up new markets for Tag-Assisted Peptide Synthesis (TAPS) services. Advancements in AI and machine learning are revolutionizing peptide design and synthesis planning, enabling faster development cycles and more efficient synthesis workflows. Simultaneously, a greater focus on sustainability is encouraging TAPS providers to use fewer solvents (such as DMF), employ more environmentally friendly reagents, and implement waste-minimization procedures. Within this evolving landscape, C-terminal amidation synthesis plays a critical role by introducing a chemical modification at the peptide’s C-terminus, converting the carboxyl group (-COOH) into an amide group (-CONH₂), which is vital for enhancing biological activity, metabolic stability, and therapeutic efficacy.
This modification is particularly important for high-throughput screening of peptide libraries, as it enhances receptor binding and overall bioactivity. TAPS enables the efficient synthesis of such amidated peptides by leveraging solubilizing tags that facilitate purification and synthesis, followed by precise amidation. For academic and research institutions, C-terminal amidation is key to generating peptides that mimic natural biomolecules for use in proteomics, biomarker discovery, and protein interaction studies. TAPS services seamlessly integrate tag-assisted synthesis with amidation to deliver high-purity, research-grade peptides suitable for applications such as epitope mapping and assay development.
List of Prominent Players in the Tag-Assisted Peptide Synthesis (TAPS) Services Market:
- Bachem
- CordenPharma
- Biosynth (Pepscan)
- AmbioPharm
- GenScript
- CPC Scientific
- PolyPeptide Group
- TAG Copenhagen A/S
- CSBio
- Auspep
- BCN Peptides
- Peptide Institute
- Creative Peptides
- Aurigene Services
Market Dynamics:
Drivers:
Peptide drugs are increasingly utilized to treat a wide range of conditions, including cancer, metabolic disorders, cardiovascular diseases, and infectious diseases. Many of these peptides, such as cyclic peptides, long-chain sequences, and multi-disulfide peptides, pose significant challenges for traditional synthesis methods due to their structural complexity and poor solubility. Tag-Assisted Peptide Synthesis (TAPS) addresses these limitations by enabling the efficient and high-yield production of such complex peptides with enhanced purity.
Moreover, the growing demand for personalized therapies such as neoantigen-based cancer vaccines and patient-specific immunotherapies requires rapid and high-fidelity synthesis of custom peptides. TAPS is ideally suited for this purpose, offering scalable workflows that support the fast-paced development of individualized treatments. Additionally, the integration of advanced AI tools and machine learning algorithms into peptide sequence design, retrosynthesis planning, and aggregation prediction is further transforming the field. When combined with automated synthesis platforms, these technologies enhance the speed, accuracy, and scalability of TAPS services, making them indispensable in modern peptide drug development.
Challenges:
Implementing tag-assisted peptide synthesis (TAPS) presents notable challenges, primarily due to the need for specialized equipment, such as automated synthesizers and purification systems, which demand substantial upfront investment. High-purity reagents, including proprietary tags like Molecular Hiving or STag-PS, further increase the costs, as their production and quality control are resource-intensive. Additionally, TAPS demands highly skilled personnel with expertise in advanced organic chemistry and peptide synthesis, who are often difficult to find and costly to recruit or train. For smaller companies and academic labs with limited budgets, these financial and technical barriers hinder adoption, restricting access to TAPS’s cost-effective, eco-friendly benefits despite its long-term potential.
Regional Trends:
North America is expected to hold the largest market share during the forecast period. North America benefits from a robust life sciences infrastructure, strong R&D investment, and favorable FDA regulations. The U.S., in particular, drives demand due to growing chronic disease prevalence and personalized medicine programs, all supported by CDMOs utilizing advanced TAPS platforms. However, Asia-Pacific is the fastest-growing region. Growth is driven by low-cost, high-skill peptide manufacturing in China, India, South Korea, and Japan. Rising healthcare investment, favorable government initiatives, and outsourcing by global pharma companies are accelerating TAPS uptake. Asia-Pacific is experiencing a boom in contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). These facilities are increasingly adopting advanced synthesis techniques like TAPS to meet growing global demand for complex and custom peptides.
Recent Developments:
- In November 2024, AmbioPharm broke ground on a $28 million expansion at its Shanghai facility, adding 70,000 ft² of space equipped with multiple 1,000–3,000 L reactors capable of both solid-phase and liquid-phase peptide synthesis (SPPS & LPPS). This expansion is expected to enable the production of over 8 metric tons of crude peptide annually, covering fragment-based peptide synthesis workflows and supporting downstream purification, thereby reinforcing its capacity in Chemical Synthesis with Tags and Hybrid Synthesis.
- In September 2023, CordenPharma stated to have finished many facility improvements and modernizations that have improved the productivity and efficiency of SPPS peptide manufacturing, enabling a greater ability to serve both present and potential clients across an expanding range of pharmaceutical innovators. Upgrades to the current 10,000 l reactor volume with a batch size exceeding 400 kg and an annual capacity of over 2 metric tons of peptide were among the measures put into place; a 50% increase in downstream HPLC purification capacity; automation upgrades; the use of PAT for amino acid identification and intensification of the ready-to-use process with constant washing and reaction monitoring.
Segmentation of Tag-Assisted Peptide Synthesis (TAPS) Services Market.
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market – By Technology
- Chemical Synthesis with Tags
- Hybrid Synthesis
- C-Terminal Amidation Synthesis
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market – By Application
- Therapeutics
- Drug Discovery
- Research
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market – By End-User
- Pharmaceutical and Biotechnology Companies
- CDMOs/CROs
- Academic and Research Institutes
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market – By Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
